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Available online 25 March 2014AbstractBackground: Dengue is one of the most important mosquito-borne diseases. Taiwan is located in an epidemic area for dengue, and several
dengue outbreaks have been reported in southern Taiwan. Therefore, we conducted this study to determine the incidence and clinical mani-
festations of symptomatic dengue infection.
Methods: We reviewed the medical records of 177 pediatric patients (age < 16 years) who underwent serum tests for dengue (polymerase chain
reaction or capture enzyme-linked immunosorbent assay for dengue immunoglobulin M and immunoglobulin G antibodies) in the pediatric
outpatient clinic, the pediatric ward, or the emergency department of the Chi-Mei Medical Center from January 1, 2007 to December 31, 2007.
We evaluated the differences in the clinical characteristics and laboratory data between the dengue and nondengue patients.
Results: Most of the dengue cases appeared starting in July and peaked during November. In the dengue group, there were more school-age
patients (age > 7 years) and a more frequent history of mosquito contact. There was no difference in the sex distribution. Most of the
dengue patients had obvious symptoms including skin rash (79.0%), nausea/vomiting (47.4%), high fever (> 39C; 44.7%), diarrhea (26.3%),
abdominal pain (23.7%), and petechiae (15.8%). Leukopenia, thrombocytopenia, elevated aspartate aminotransferase levels, and elevated alanine
aminotransferase levels were found in 78.4%, 79.3%, 34.5%, and 29.0% of the patients, respectively. Nondengue patients showed elevated C-
reactive protein levels (57.5%).
Conclusion: Dengue is commonly found in older pediatric patients and is rare in infants. High fever and skin and gastrointestinal manifestations
were usually found in dengue patients. The laboratory findings of leukopenia, thrombocytopenia, elevated levels of liver enzymes, and low C-
reactive protein levels were common in dengue patients, and these markers could help confirm the suspicion of pediatric dengue infection.
Copyright  2014, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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Dengue virus is endemic in tropical and subtropical areas and
is themost common cause of arboviral disease in theworld.1,2 In
adults, the classical presentation of dengue includes fever,* Corresponding author. Emergency Department, Chi-Mei Medical Center,
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2211-5587/Copyright  2014, Taiwan Society of Emergency Medicine. Publishedheadache, myalgia, and skin rash.2 However, the clinical fea-
tures of denguevarywith age, and secondary infections aremore
likely to result in severe symptoms.1 In addition, the limitations
of verbal expression in the pediatric population might influence
the presentation of dengue and make the diagnosis of dengue
more difficult in children.
Taiwan is located in an epidemic area of dengue, and
several dengue outbreaks have been reported in southern
Taiwan.3,4 The accurate diagnosis and reporting of dengue
infection is crucial for public health and disease control.by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. The monthly distribution of dengue patients.
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scriptions of the clinical features and laboratory findings for
pediatric dengue patients. Therefore, we conducted a retro-
spective study to identify the common clinical and laboratory
findings for pediatric dengue patients.
2. Materials and methods
This study was approved by the Institutional Review Board
for Human Research of the Chi-Mei Medical Center, Tainan,
Taiwan. We reviewed the charts of all pediatric patients (age <
16 years) who underwent serum tests for dengue [polymerase
chain reaction or capture enzyme-linked immunosorbent assay
for dengue immunoglobulin (Ig)M and IgG antibodies] in the
pediatric outpatient clinic, the pediatric ward or the emergency
department of the Chi-Mei Medical Center from January 1,
2007 to December 31, 2007. These patients were considered
clinically suspected dengue cases.
All suspected cases were reported to the Centers for Dis-
ease Control (CDC), Taiwan, R.O.C. and blood samples from
these patients were sent to the CDC. The diagnosis of dengue
was established by the official report from the CDC. The
diagnostic criteria for dengue included typical manifestations
and positive results for virus isolation, dengue polymerase
chain reaction, the presence of dengue nonstructural protein 1
antibody or the presence of paired dengue IgM and IgG an-
tibodies with seroconversion or a  4-fold increase. The pa-
tients whose first serum test for dengue IgM and IgG
antibodies was positive but who did not meet the other diag-
nostic criteria were classified as probable cases.5
We reviewed the cases of 177 patients during the study
period and excluded 18 patients because they were probable
cases. Among the included patients, 38 patients had dengue,
and the other 121 patients had a different disease. We used the
Chi-square test to evaluate the differences in the clinical
characteristics and laboratory data between the dengue and
nondengue patients.
3. Results3.1. General characteristics and clinical featuresFig. 2. Comparison of the clinical characteristics of the dengue and nondengue
patients.The monthly distribution of dengue patients is shown in
Fig. 1. The dengue cases appeared starting in July and peaked
in November, which is in line with the temporal distribution of
dengue infections in Taiwan.6 The numbers of dengue and
nondengue patients increased simultaneously. A comparison
of the general characteristics of the dengue and nondengue
patients revealed that both groups showed a slight male pre-
dominance (60.5% vs. 55.4%, p ¼ 0.58). The age of the
dengue patients varied from 1 year to 16 years. None of the
dengue patients and 11 of the nondengue patients were
younger than 1 year. There were more school-age patients (>
7 years) in the dengue group than in the nondengue group
(73.7% vs. 43.8%, p < 0.05). There was a trend of more
mosquito contact for the dengue patients (39.5% vs. 24.0%,
p ¼ 0.06; Fig. 2).We selected 10 common clinical features that were present
in > 15% of the dengue patients: skin rash, nausea/vomiting,
fever > 39C, cough, anorexia, diarrhea, myalgia/arthralgia,
abdominal pain, malaise, and petechiae. A comparison of the
frequencies of these clinical features between the dengue and
nondengue groups revealed that there were statistically sig-
nificant differences in the occurrence of skin rash, nausea/
vomiting, fever > 39C, diarrhea, abdominal pain, and pete-
chiae between the groups (Table 1).3.2. Laboratory findingsSerum tests to determine the complete blood cell count and
levels of C-reactive protein (CRP), alanine aminotransferase
(AST), and aspartate aminotransferase (ALT) were performed
in 154/159 (96.9%), 126/159 (79.2%), and 65/159 (40.9%),
respectively, of the reviewed patients. In the dengue group, we
found that 27/37 (73.0%) were leukopenic (white cell count <
3.5  109/L), 32/37 (78.4%) were thrombocytopenic (platelets
< 150  109/L), 23/29 (79.3%) had elevated AST levels, 10/
29 (34.5%) had elevated ALT levels and only 9/31 (29.0%)
had elevated CRP levels (> 6 mg/L). By contrast, the non-
dengue group contained fewer patients with leucopenia (22/
Table 1
Comparison of 10 common clinical features between dengue and nondengue
patients.
Clinical features Dengue
(n ¼ 38)
Nondengue
(n ¼ 121)
pa
Skin rash 79.0 29.0 < 0.05
Nausea/vomiting 47.4 15.7 < 0.05
Fever > 39C 44.7 21.5 < 0.05
Diarrhea 26.3 10.0 < 0.05
Abdominal pain 23.7 5.0 < 0.05
Petechiae 15.8 2.5 < 0.05
Cough 44.7 41.3 0.71
Anorexia 34.2 24.8 0.25
Myalgia/arthralgia 26.3 18.2 0.27
Malaise 21.1 18.2 0.69
Data are presented as %.
a Chi-square test.
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AST (5/36, 14.0%) and ALT (2/36, 5.6%) levels, but more
than half of nondengue patients had elevated CRP levels (43/
95, 57.5%). Table 2 lists the average  standard deviation and
the percentage of abnormal laboratory findings for the dengue
and nondengue patients.
4. Discussion
The rainy season in southern Taiwan, the area in which the
Chi-Mei Medical Center is located, starts in May and ends in
September.7 Hot and wet environmental conditions increase
the number of Aedes aegypti mosquitoes, the dengue vector.8
A study by Wu et al9 revealed that high temperature and
high humidity have the most prominent effect on the occur-
rence of dengue at a time lag of 2 months. Accordingly, the
numbers of dengue patients increased starting in July and
peaked in November. The presence of dengue patients in-
dicates that physicians should consider dengue infection in the
differential diagnosis of febrile patients. However, in most
months with a high incidence of dengue, the percentage ofTable 2
Mean  standard deviation and percentage of abnormal laboratory findings for
dengue and nondengue patients while in the hospital or at admission.
Laboratory data Dengue Nondengue pa
WBC  109/L 3.11  1.68 7.43  3.72 d
WBC < 3.5  109/L 27/37 (73.0) 22/117 (18.8) < 0.05
Platelets  109/L 123  30 236  92 d
Platelets < 150  109/L 32/37 (78.4) 28/117 (23.1) < 0.05
AST, U/L 127  95 48  86 d
AST > 50 U/L 23/29 (79.3) 5/36 (14.0) < 0.05
ALT, U/L 57  55 31  59 d
ALT > 50 U/L 10/29 (34.5) 2/36 (5.6) < 0.05
CRP, mg/L 5  5 21  32 d
CRP > 6 mg/L 9/31 (29.0) 43/95 (57.5) < 0.05
Data are presented as n (%) or mean  SD.
ALT ¼ aspartate aminotransferase; AST ¼ alanine aminotransferase;
CRP ¼ C-reactive protein.
a Chi-square test.negative serum tests for dengue was > 50%. This result im-
plies that it is still difficult for pediatricians and emergency
physicians to differentiate dengue infection from other febrile
diseases in pediatric patients.
The average age of dengue patients was higher than that of
nondengue patients. Almost three-quarters of the dengue pa-
tients were older than 7 years, and no dengue patient was
younger than 1 year. This finding is similar to the results of a
survey in Thailand that found that most pediatric dengue pa-
tients are in the age group of 5e14 years.10 School-age chil-
dren are more likely to spend time outdoors and thus are at a
higher risk of being bitten by mosquitoes. Additionally,
compared with infants and toddlers, older children have better
verbal skills and can better describe their symptoms. These
factors might contribute to the higher incidence of dengue in
school-age children.
The classical features of dengue infection in adults include
high fever, headache, myalgia/arthralgia, nausea/vomiting, and
skin rash.2 In our study, we found that skin rash, nausea/vom-
iting, fever > 39C, cough, anorexia, diarrhea, myalgia/
arthralgia, abdominal pain, malaise, and petechiae were the
most common symptoms. Nevertheless, these symptoms are
also present in patients with various other pediatric infectious
diseases, and the presence of these symptoms does not confirm
dengue infection. Accordingly, we compared the frequencies of
these clinical features in dengue and nondengue patients to
identify the predominant symptoms of dengue infection. We
found that skin rash, nausea/vomiting, fever > 39C, diarrhea,
abdominal pain, and petechiae were commonly observed in
dengue patients and that cough, anorexia, myalgia/arthralgia,
and malaise were nonspecific presentations in both dengue and
nondengue patients. We found the expression of the nonspecific
symptoms, including anorexia, myalgia/arthralgia, andmalaise,
requires a higher verbal ability and that the ability of a patient to
report these symptoms cannot be adequately replaced by the
observations of the patient’s family. The different levels of
verbal ability might partially explain the differences in the
clinical features in adult and pediatric dengue patients.
There were obvious differences in the results of the serum
tests between the dengue and nondengue groups. Leukopenia
and thrombocytopenia are commonly present in patients with
dengue, which may contribute to early bone-marrow sup-
pression combined with increased peripheral destruction of
cells during the febrile and early convalescent phases of
dengue.1 These unique findings are seldom found in children
who do not have dengue.
The liver is an organ that can be infected by the dengue virus.
The histological hepatic changes reported for dengue include
microvesicular steatosis, hepatocellular necrosis, Kupffer cell
hyperplasia and destruction, Councilman bodies, and cellular
infiltrates in the portal tract.11 Clinically, hepatomegaly and
increased serum liver enzyme levels occur frequently in dengue
patients.11e13 The elevation of the serum AST level appears to
be greater than the elevation of theALT level,which differs from
the characteristics of viral hepatitis (ALT levels are usually
higher than AST levels).14 We found similar findings in our
pediatric dengue patients, and elevated AST and ALT levels
56 S.-T. Pan et al. / Journal of Acute Medicine 4 (2014) 53e56could serve as guides to distinguish pediatric dengue patients
from children with other febrile diseases.
Determining the CRP level is a useful serum test to identify
severe bacterial infection in febrile children.15 We found that
elevated CRP levels are seldom present in dengue patients and
that the elevation in the CRP levels is small when present (the
highest CRP level in the dengue group was 12.7 mg/L).
Markedly increased CRP levels are less likely to occur in
dengue patients, and therefore, pediatricians and emergency
physicians should consider other febrile diseases in the dif-
ferential diagnosis when increased CRP levels are found.
In conclusion, dengue is commonly found in older pediatric
patients and is rare in infants. High fever and skin and
gastrointestinal presentations were usually found in dengue
patients. Laboratory findings including leukopenia, thrombo-
cytopenia, elevated liver enzyme levels, and low CRP levels
are commonly present in dengue patients, and these markers
could help confirm the suspicion of pediatric dengue infection.
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